会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明授权
    • Apparatus and method for the preparation of a radiopharmaceutical
formulation
    • 用于制备放射性药物制剂的装置和方法
    • US5397902A
    • 1995-03-14
    • US167685
    • 1993-12-15
    • James F. CastnerBobby E. CorryThomas D. HarrisRichard J. Looby
    • James F. CastnerBobby E. CorryThomas D. HarrisRichard J. Looby
    • G21G4/08A61K51/00G21F5/015G21K5/00G21F5/00
    • G21F5/015
    • Apparatus and method for producing a radiopharmaceutical formulation utilize a radiation-shielding container for receiving a vial having the non-radioactive components necessary to form a radiopharmaceutical formulation therein. A mixture of such non-radioactive components and a radioactive liquid added thereto is both heated and cooled using a thermoelectric element. The container comprises a hollow outer shielding member formed from a radiation shielding material and a vial holder formed from a highly heat conductive material received therewithin. The vial holder includes a skirt portion that defines a socket. The socket is sized to receive in an intimate heat transmissive relationship a mounting projection that is itself connected in thermally conductive contact with the thermoelectric element. Using the thermoelectric heating and cooling element, heat is both applied to and removed from the radioactive liquid and the non-radioactive components within the vial while the vial is held within the vial holder within the radiation shielding container, thereby to produce a radiopharmaceutical formulation within the vial.
    • 用于制备放射性药物制剂的装置和方法利用辐射屏蔽容器来接收具有在其中形成放射性药物制剂所必需的非放射性成分的小瓶。 使用热电元件将这种非放射性组分和加入其中的放射性液体的混合物加热和冷却。 容器包括由辐射屏蔽材料形成的中空外屏蔽构件和由其中容纳的高导热材料形成的小瓶支架。 瓶保持器包括限定插座的裙部。 插座的尺寸被设计成以紧密的热传导关系接收安装突起,该安装突起本身与热电元件的导热接触连接。 使用热电加热和冷却元件,当将小瓶保持在辐射屏蔽容器内的小瓶保持器内时,热量被施加到放射性液体和小瓶内的非放射性组分中并从其中移除,由此产生放射性药物制剂 小瓶。
    • 8. 发明授权
    • CXCR4 receptor compounds
    • CXCR4受体化合物
    • US09155795B2
    • 2015-10-13
    • US13580775
    • 2011-02-25
    • Richard J. LoobyBoris Tchernychev
    • Richard J. LoobyBoris Tchernychev
    • C07K7/08C07K14/00A61K47/48C07K14/715A61K38/00
    • A61K47/48046A61K38/00A61K47/543A61K47/554C07K14/7158
    • The invention relates generally to compounds which are allosteric modulators {e.g., positive and negative allosteric modulators, and allosteric agonists) of the G protein coupled receptor for stromal derived factor 1 (SDF-I), also known as the CXCR4 receptor. The CXCR4 receptor compounds are derived from the intracellular loops and domains of the CXCR4 receptor. The invention also relates to the use of these CXCR4 receptor compounds and pharmaceutical compositions comprising the CXCR4 receptor compounds in the treatment of diseases and conditions associated with CXCR4 modulation such as bone marrow transplantation, chemosensitization, cancer, metastatic disease (e.g., cancer), auto-immune disease (e.g., rheumatoid arthritis), fibrosis disease (e.g., pulmonary), AIDS infection, cardiovascular disease, uveitis, inflammatory diseases, celiac disease HIV infection and stem cell-based regenerative medicine.
    • 本发明一般涉及用于间质衍生因子1(SDF-1)(也称为CXCR4受体)的G蛋白偶联受体的变构调节剂(例如,正和负变构调节剂和变构兴奋剂)的化合物。 CXCR4受体化合物衍生自CXCR4受体的细胞内环和结构域。 本发明还涉及这些CXCR4受体化合物和包含CXCR4受体化合物的药物组合物在治疗与CXCR4调节相关的疾病和病症如骨髓移植,化学敏化,癌症,转移性疾病(例如癌症),自动化 免疫性疾病(例如类风湿性关节炎),纤维化疾病(例如肺部),艾滋病感染,心血管疾病,葡萄膜炎,炎性疾病,腹腔疾病HIV感染和干细胞再生医学。
    • 9. 发明申请
    • CXCR4 Receptor Compounds
    • CXCR4受体化合物
    • US20130005944A1
    • 2013-01-03
    • US13580775
    • 2011-02-25
    • Richard J. LoobyBoris Tchernychev
    • Richard J. LoobyBoris Tchernychev
    • C07K7/08C07K14/00
    • A61K47/48046A61K38/00A61K47/543A61K47/554C07K14/7158
    • The invention relates generally to compounds which are allosteric modulators {e.g., positive and negative allosteric modulators, and allosteric agonists) of the G protein coupled receptor for stromal derived factor 1 (SDF-I), also known as the CXCR4 receptor. The CXCR4 receptor compounds are derived from the intracellular loops and domains of the CXCR4 receptor. The invention also relates to the use of these CXCR4 receptor compounds and pharmaceutical compositions comprising the CXCR4 receptor compounds in the treatment of diseases and conditions associated with CXCR4 modulation such as bone marrow transplantation, chemosensitization, cancer, metastatic disease (e.g., cancer), auto-immune disease (e.g., rheumatoid arthritis), fibrosis disease (e.g., pulmonary), AIDS infection, cardiovascular disease, uveitis, inflammatory diseases, celiac disease HIV infection and stem cell-based regenerative medicine.
    • 本发明一般涉及用于间质衍生因子1(SDF-1)(也称为CXCR4受体)的G蛋白偶联受体的变构调节剂(例如,正和负变构调节剂和变构兴奋剂)的化合物。 CXCR4受体化合物衍生自CXCR4受体的细胞内环和结构域。 本发明还涉及这些CXCR4受体化合物和包含CXCR4受体化合物的药物组合物在治疗与CXCR4调节相关的疾病和病症如骨髓移植,化学敏化,癌症,转移性疾病(例如癌症),自动化 免疫性疾病(例如类风湿性关节炎),纤维化疾病(例如肺部),艾滋病感染,心血管疾病,葡萄膜炎,炎性疾病,腹腔疾病HIV感染和干细胞再生医学。